Pay in 4 interest-free payments of $5.56 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
Pick a time you can maintain consistently
Every person is different and has a different skin tone and skin pigmentation and thus results and treatment required varies
Pentadecapeptide BPC 157 attenuates disturbances induced by neuroleptics: the effect [PMID: 10499368] Laboratory literature summary: Pentadecapeptide BPC 157 attenuates disturbances induced by neuroleptics: the effect on catalepsy and gastric ulcers in mice and rats
A.SmithP
Allison Whitten Pfizer's LITFULO meets primary endpoints in Phase 3 vitiligo trials Pfizer reported topline results from two Phase 3 trials of LITFULO (ritlecitinib) in nonsegmental vitiligo, with both the 50 and 100 milligram once-daily doses meeting co-primary endpoints for facial and total body repigmentation over placebo at Week 52
US$ 20.36
US$ 21.07
US$ 27.19
US$ 22.26
US$ 27.14
US$ 23.21
US$ 21.10
US$ 20.64
US$ 25.84
US$ 25.66
US$ 24.65
US$ 29.45
US$ 27.10
US$ 22.87
US$ 22.92
